Maculaser has been awarded a 400kEUR Deep Tech Accelerator grant from Business Finland. This brings our total private and public funding […]
Maculaser awarded Deep Tech Accelerator grant funding Read more ›
Explore the Frontier of AMD Treatment Research: Mooud Amirkavei’s dissertation at Aalto University School of Science, defended on 2023-05-26, offers
Dissertation sheds light on the effects of hormetic heat on AMD Read more ›
Maculaser, a company developing treatments for retinal disorders that affect millions of people worldwide and that currently have no effective
Maculaser receives Instrumentarium Science Foundation grant Read more ›
Maculaser’s novel temperature-controlled subthreshold laser therapy and method for treating diabetic macular edemas is currently being presented at the world’s leading
Maculaser showcased in PhotonicsWest BIOS Read more ›
Maculaser’s Chief Scientific Officer Teemu Turunen presented the results of our clinical usability trial in Visionarium XX, an acknowledged conference
Maculaser in Visionarium XX, conference for wide-scope vision research Read more ›
The start of the autumn has been filled with both ophthalmology and investment events. Latest, the past two days in
Nordic Life Science Days – A rising star Read more ›
This study introduces a new method for monitoring and controlling the temperature of the retina during laser treatments, using a
A study describes the basis of retinal temperature monitoring for clinical use Read more ›
Marja Pitkänen’s doctoral thesis at Aalto University, defended on June 12, 2020, presents a groundbreaking exploration in the field of
Dissertation pioneers the use of ERG as a retinal temperature monitor Read more ›
The paper explores a new laser-induced heat treatment method for the retina, focusing on inducing a protective response in the
Induction of protective response with heat treatment shown in mouse RPE Read more ›
